Factory Supply 99% Estrogen Original Powder Beta-Estradiol CAS 50-28-2 with Safe Delivery

China Factory Supply 99% Estrogen Original Powder Beta-Estradiol CAS 50-28-2 with Safe Delivery, Find details about China Beta-Estradiol, 50-28-2 from Factory Supply 99% Estrogen Original Powder Beta-Estradiol CAS 50-28-2 with Safe Delivery

Model NO.
Beta-ESTRADIOL
CAS
50-28-2
Appearance
White Powder
Mf
C18h24o2
MW
272.39
Einecs No.
200-023-8
Melting Point
178-179
Boiling Point
355.44
Density
1.0708
Merck
14, 3703
Brn
1914275
Storage
Room Temperature Away From Light
Shelf Life
2 Years
Deliver Time
7-10days
Trademark
Biolang
Transport Package
100g, 1kg, 25kg
Specification
100g, 1kg, 25KG
Origin
Guangzhou China
HS Code
29372390
Model NO.
Beta-ESTRADIOL
CAS
50-28-2
Appearance
White Powder
Mf
C18h24o2
MW
272.39
Einecs No.
200-023-8
Melting Point
178-179
Boiling Point
355.44
Density
1.0708
Merck
14, 3703
Brn
1914275
Storage
Room Temperature Away From Light
Shelf Life
2 Years
Deliver Time
7-10days
Trademark
Biolang
Transport Package
100g, 1kg, 25kg
Specification
100g, 1kg, 25KG
Origin
Guangzhou China
HS Code
29372390
Factory Supply 99% Estrogen Original Powder Beta-ESTRADIOL CAS 50-28-2 with Safe Delivery
Factory Supply 99% Estrogen Original Powder Beta-Estradiol CAS 50-28-2 with Safe Delivery
Detailed Product Information
 Factory Supply 99% Estrogen Original Powder Beta-Estradiol CAS 50-28-2 with Safe DeliveryFactory Supply 99% Estrogen Original Powder Beta-Estradiol CAS 50-28-2 with Safe Delivery
Description

Estradiol (E2), also spelled oestradiol, is an estrogen steroid hormone and the major female sex hormone. It is involved in the regulation of the estrous and menstrual female reproductive cycles. Estradiol is responsible for the development of female secondary sexual characteristics such as the breasts, widening of the hips, and a female-associated pattern of fat distribution and is important in the development and maintenance of female reproductive tissues such as the mammary glands, uterus, and vagina during puberty, adulthood, and pregnancy. It also has important effects in many other tissues including bone, fat, skin, liver, and the brain.

Though estradiol levels in males are much lower than in females, estradiol has important roles in males as well. Apart from humans and other mammals, estradiol is also found in most vertebrates and crustaceans, insects, fish, and other animal species.

Estradiol is produced especially within the follicles of the ovaries, but also in other tissues including the testicles, the adrenal glands, fat, liver, the breasts, and the brain. Estradiol is produced in the body from cholesterol through a series of reactions and intermediates. The major pathway involves the formation , which is then converted by aromatase into estrone and is subsequently converted into estradiol. Alternatively,  which can then be converted into estradiol. Upon menopause in females, production of estrogens by the ovaries stops and estradiol levels decrease to very low levels.

In addition to its role as a natural hormone, estradiol is used as a medication, for instance in menopausal hormone therapy and feminizing hormone therapy for transgender women; for information on estradiol as a medication, see the estradiol (medication) article.


Factory Supply 99% Estrogen Original Powder Beta-Estradiol CAS 50-28-2 with Safe Delivery

Biological Function

Sexual Development

The development of secondary sex characteristics in women is driven by estrogens, to be specific, estradiol. These changes are initiated at the time of puberty, most are enhanced during the reproductive years, and become less pronounced with declining estradiol support after menopause. Thus, estradiol produces breast development, and is responsible for changes in the body shape, affecting bones, joints, and fat deposition. In females, estradiol induces breast development, widening of the hips, a feminine fat distribution (with fat deposited particularly in the breasts, hips, thighs, and buttocks), and maturation of the vagina and vulva, whereas it mediates the pubertal growth spurt and epiphyseal closure (thereby limiting final height) in both sexes.

Reproduction

Female Reproductive System

In the female, estradiol acts as a hormone for tissue of the reproductive organs, supporting the lining of the vagina, the cervical glands, the endometrium, and the lining of the fallopian tubes. It enhances growth of the myometrium. Estradiol appears necessary to maintain oocytes in the ovary. During the menstrual cycle, estradiol produced by the growing follicles triggers, via a positive feedback system, the hypothalamic-pituitary events that lead to the hormone surge, inducing ovulation. In the luteal phase, estradiol, in conjunction with progesterone, prepares the endometrium for implantation. During pregnancy, estradiol increases due to placental production. The effect of estradiol, together with estrone and estriol, in pregnancy is less clear. They may promote uterine blood flow, myometrial growth, stimulate breast growth and at term, promote cervical softening and expression of myometrial oxytocin receptors. In baboons, blocking of estrogen production leads to pregnancy loss, suggesting estradiol has a role in the maintenance of pregnancy. Research is investigating the role of estrogens in the process of initiation of labor. Actions of estradiol are required before the exposure of progesterone in the luteal phase.

Male Reproductive System

The effect of estradiol (and estrogens in general) upon male reproduction is complex. Estradiol is produced by action of aromatase mainly in the Leydig cells of the mammalian testis, but also by some germ cells and the Sertoli cells of immature mammals. It functions (in vitro) to prevent apoptosis of male sperm cells. While some studies in the early 1990s claimed a connection between globally declining sperm counts and estrogen exposure in the environment, later studies found no such connection, nor evidence of a general decline in sperm counts. Suppression of estradiol production in a subpopulation of subfertile men may improve the semen analysis.

Males with certain sex chromosome genetic conditions, such as Klinefelter's syndrome, will have a higher level of estradiol.

Skeletal System

Estradiol has a profound effect on bone. Individuals without it (or other estrogens) will become tall and eunuchoid, as epiphyseal closure is delayed or may not take place. Bone density is also affected, resulting in early osteopenia and osteoporosis. Low levels of estradiol may also predict fractures, with post-menopausal women having the highest incidence of bone fracture. Women past menopause experience an accelerated loss of bone mass due to a relative estrogen deficiency

Skin Health

The estrogen receptor, as well as the progesterone receptor, have been detected in the skin, including in keratinocytes and fibroblasts. At menopause and thereafter, decreased levels of female sex hormones result in atrophy, thinning, and increased wrinkling of the skin and a reduction in skin elasticity, firmness, and strength. These skin changes constitute an acceleration in skin aging and are the result of decreased collagen content, irregularities in the morphology of epidermal skin cells, decreased ground substance between skin fibers, and reduced capillaries and blood flow. The skin also becomes more dry during menopause, which is due to reduced skin hydration and surface lipids (sebum production). Along with chronological aging and photoaging, estrogen deficiency in menopause is one of the three main factors that predominantly influences skin aging.

Hormone replacement therapy consisting of systemic treatment with estrogen alone or in combination with a progestogen, has well-documented and considerable beneficial effects on the skin of postmenopausal women. These benefits include increased skin collagen content, skin thickness and elasticity, and skin hydration and surface lipids. Topical estrogen has been found to have similar beneficial effects on the skin. In addition, a study has found that topical 2% progesterone cream significantly increases skin elasticity and firmness and observably decreases wrinkles in peri- and postmenopausal women. Skin hydration and surface lipids, on the other hand, did not significantly change with topical progesterone. These findings suggest that progesterone, like estrogen, also has beneficial effects on the skin, and may be independently protective against skin aging.

Nervous System

Estrogens can be produced in the brain from steroid precursors. As antioxidants, they have been found to have neuroprotective function.

The positive and negative feedback loops of the menstrual cycle involve ovarian estradiol as the link to the hypothalamic-pituitary system to regulate gonadotropins. (See Hypothalamic-pituitary-gonadal axis.)

Estrogen is considered to play a significant role in women's mental health, with links suggested between the hormone level, mood and well-being. Sudden drops or fluctuations in, or long periods of sustained low levels of estrogen may be correlated with significant mood-lowering. Clinical recovery from depression postpartum, perimenopause, and postmenopause was shown to be effective after levels of estrogen were stabilized and/or restored.

Recently, the volumes of sexually dimorphic brain structures in transgender women were found to change and approximate typical female brain structures when exposed to estrogen concomitantly with androgen deprivation over a period of months, suggesting that estrogen and/or androgens have a significant part to play in sex differentiation of the brain, both prenatally and later in life.

There is also evidence the programming of adult male sexual behavior in many vertebrates is largely dependent on estradiol produced during prenatal life and early infancy. It is not yet known whether this process plays a significant role in human sexual behavior, although evidence from other mammals tends to indicate a connection.

Estrogen has been found to increase the secretion of oxytocin and to increase the expression of its receptor, the oxytocin receptor, in the brain. In women, a single dose of estradiol has been found to be sufficient to increase circulating oxytocin concentrations.

Gynecological Cancers

Estradiol has been tied to the development and progression of cancers such as breast cancer, ovarian cancer and endometrial cancer. Estradiol affects target tissues mainly by interacting with two nuclear receptors called estrogen receptor α (ERα) and estrogen receptor β (ERβ). One of the functions of these estrogen receptors is the modulation of gene expression. Once estradiol binds to the ERs, the receptor complexes then bind to specific DNA sequences, possibly causing damage to the DNA and an increase in cell division and DNA replication. Eukaryotic cells respond to damaged DNA by stimulating or impairing G1, S, or G2 phases of the cell cycle to initiate DNA repair. As a result, cellular transformation and cancer cell proliferation occurs.

Cardiovascular System

Estrogen affects certain blood vessels. Improvement in arterial blood flow has been demonstrated in coronary arteries.During pregnancy, high levels of estrogens, namely estradiol, increase coagulation and the risk of venous thromboembolism.



Related Products
Factory Supply 99% Estrogen Original Powder Beta-Estradiol CAS 50-28-2 with Safe Delivery

Factory Supply 99% Estrogen Original Powder Beta-Estradiol CAS 50-28-2 with Safe DeliveryFactory Supply 99% Estrogen Original Powder Beta-Estradiol CAS 50-28-2 with Safe DeliveryFactory Supply 99% Estrogen Original Powder Beta-Estradiol CAS 50-28-2 with Safe DeliveryFactory Supply 99% Estrogen Original Powder Beta-Estradiol CAS 50-28-2 with Safe DeliveryFactory Supply 99% Estrogen Original Powder Beta-Estradiol CAS 50-28-2 with Safe DeliveryFactory Supply 99% Estrogen Original Powder Beta-Estradiol CAS 50-28-2 with Safe Delivery